• Title/Summary/Keyword: poly(L-lactide)

Search Result 174, Processing Time 0.024 seconds

DEVELOPMENT OF MOLDABLE BONE REGENERATING THERAPEUTICS USING PARTIALLY PURIFIED PORCINE BONE MORPHOGENETIC PROTEIN AND BIORESORBABLE POLYMER (Poly(L-lactide)와 돼지골기질에서 추출 부분정제한 골형성단백을 이용한 조형가능성 골형성유도체의 개발)

  • Lee, Jong-Ho;Chung, Chong-Pyung;Lee, Sung-Jin
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.26 no.2
    • /
    • pp.179-185
    • /
    • 2000
  • The purpose of this study was to develop an osteogenic, biodegradable material using polymer and BMP. It was designed to have structural function and be moldable, for the reconstruction of load bearing areas and deformities of various configurations. Bone apatite was added to Poly(L-lactide)(PLLA) and made porous for osteoconductability and ease of BMP loading. The materials, with or without BMP purified from porcine bone matrix, were evaluated in cranial bone defect models in rats for biocompatibility and bone regeneration capability. The following results were obtained: The PLLA-BMP material with BMP added to the polymer showed 30% healing of cranial bone defects in rats during the 2 weeks to 3 months period of observation. The moldable PLLA agent without BMP also showed 25% bone healing capacity. Although new bone formation was incomplete in the critical size defect of rat cranium, it can be concluded that the unique moldability of those agents makes them useful for the reconstruction of various bone defects and maxillofacial deformities.

  • PDF

Cellular Uptake Behavior of Poly(D,L-lactide-co-glycolide) Nanoparticles Derivatized with HIV-1 Tat49-57 Peptide (Abbreviated Title: Tat-PLGA Nanoparticles)

  • Park, Ju-Young;Nam, Yoon-Sung;Kim, Jun-Oh;Han, Sang-Hoon;Chang, Ih-Seop
    • Journal of Pharmaceutical Investigation
    • /
    • v.34 no.2
    • /
    • pp.101-106
    • /
    • 2004
  • This work aims at examining the cellular uptake behavior of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles derivatized with a protein transduction domain (PTD) using HeLa cells. For this purpose, $Tat_{49-57}$ peptide derived from transcriptional activation (Tat) protein of HIV type-1 was covalently conjugated to the terminal end of PLGA. Nanoparticles were ten prepared with the $Tat_{49-57}-PLGA$ conjugates by a spontaneous phase inversion method. The prepared particles had a mean diameter of ca. 84 nm, as measured by dynamic light scattering. The interaction of the Tat-PLGA nanoparticles with cells was examined by using confocal laser scanning microscopy. It was found tat Tat-PLGA nanoparticles incubated with HeLa cells could efficiently translocate into cytoplasm, while plain PLGA nanoparticles showed negligible cellular uptake. In addition, even at $4^{\circ}C$ or in the presence of sodium azide significant cellular internalization of Tat-PLGA nanoparticles was still observed. These results indicate that a non-endocytotic translocation mechanism might be involved in the cellular uptake of Tat-PLGA nanoparticles.

Preparation of L-PLA Microparticles using Pure and Cosolvent-modified Supercritical Carbon Dioxide (순수 초임계 이산화탄소와 극성 공용매로 변형된 초임계 이산화탄소를 이용한 L-PLA 미세입자 제조)

  • 김재훈;이상윤;김병용;유종훈;임교빈
    • KSBB Journal
    • /
    • v.18 no.5
    • /
    • pp.385-392
    • /
    • 2003
  • Biodegradable poly (L-lactide) (L-PLA) solution in methylene chloride was precipitated into microparticles by using supercritical carbon dioxide modified with polar cosolvents. The effects of the amount of polar cosolvents, solution concentration, temperature, and solution flow rate on the formation of microparticles were investigated. The mean particle size was found to increase with the increase of solution concentration and flow rate. It was also observed that the particle size not only increases but the size distribution also becomes less uniform as the temperature increases. The percent recovery of microparticles was found to be 30∼40% at all experimental conditions. The supercritical carbon dioxide modified with methanol and ethanol was employed to enhance the recovery, resulting in significant improvement up to about 80 and 70%, for methanol and ethanol, respectively. Furthermore, the mean diameter of L-PLA microparticles was found to be less than 1 $\mu\textrm{m}$ for both cosolvents.

Doxorubicin Release from Core-Shell Type Nanoparticles of Poly(DL-lactide-co-glycolide)-Grafted Dextran

  • Jeong, Young-Il;Choi, Ki-Choon;Song, Chae-Eun
    • Archives of Pharmacal Research
    • /
    • v.29 no.8
    • /
    • pp.712-719
    • /
    • 2006
  • In this study, we prepared core-shell type nanoparticles of a poly(DL-lactide-co-glycolide) (PLGA) grafted-dextran (DexLG) copolymer with varying graft ratio of PLGA. The synthesis of the DexLG copolymer was confirmed by $^1H$ nuclear magnetic resonance (NMR) spectroscopy. The DexLG copolymer was able to form nanoparticles in water by self-aggregating process, and their particle size was around $50\;nm{\sim}300\;nm$ according to the graft ratio of PLGA. Morphological observations using a transmission electron microscope (TEM) showed that the nanoparticles of the DexLG copolymer have uniformly spherical shapes. From fluorescence probe study using pyrene as a hydrophobic probe, critical association concentration (CAC) values determined from the fluorescence excitation spectra were increased as increase of DS of PLGA. $^1H-NMR$ spectroscopy using $D_2O$ and DMSO approved that DexLG nanoparticles have core-shell structure, i.e. hydrophobic block PLGA consisted inner-core as a drug-incorporating domain and dextran consisted as a hydrated outershell. Drug release rate from DexLG nano-particles became faster in the presence of dextranase in spite of the release rate not being significantly changed at high graft ratio of PLGA. Core-shell type nanoparticles of DexLG copolymer can be used as a colonic drug carrier. In conclusion, size, morphology, and molecular structure of DexLG nanoparticles are available to consider as an oral drug targeting nanoparticles.

Preparation of BCNU-loaded PLGA Wafers and In Vitro Release Behavior (BCNU 함유 PLGA 웨이퍼의 제조와 생체외 방출거동)

  • 성하수;문대식;강길선;이정식;이해방
    • Polymer(Korea)
    • /
    • v.26 no.1
    • /
    • pp.128-138
    • /
    • 2002
  • 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU, Carmustine)-loaded poly(D, L-lactide-co-glycolide) (PLGA, lactide/glycolide mole ratio 75 : 25) microparticles were prepared and fabricated into wafers in an attempt to study the possibility for the treatment of malignant glioma by direct inserting the wafers to the tumor or the cavity remained after surgical resection of the tumor. SEM observation of the microparticles prepared by spray drying method revealed that the microparticles were spherical, i. e. microspheres. Significant reduction of the crystallinity of BCNU encapsulated in PLGA was confirmed by X-ray diffraction and differential scanning calorimetry analyses of the BCNU-loaded PLGA microparticles. Release pattern of BCNU was dependent on several preparation parameters, such as the molecular weight and concentration of PLGA, and initial BCNU loading amount, etc. In vitro release of BCNU was prolonged over 8 weeks with close to zero-order release pattern after initial burst effect. Observations of morphological change of wafers and pH change of release media during release test period confirmed that hydration and degradation of PLGA would be facilitated with an increase of BCNU-loading amount.

Preparation of Biodegradable PLGA Microspheres for Sustained Local Anesthesia and Their in vitro Release Behavior (지속적인 국소마취를 위한 생분해성 PLGA 미립구의 제조와 생체외 방출 거동)

  • 조진철;강길선;최학수;이종문;이해방
    • Polymer(Korea)
    • /
    • v.24 no.5
    • /
    • pp.728-735
    • /
    • 2000
  • Fentanyl-loaded biodegradable poly(L-lactide-co-glycolide) (75 : 25 by mole ratio of lactide to glycolide, PLGA) microspheres (MSs) were prepared to study the possibility for long-acting local anesthesia. We developed the fentanyl base (FB, slightly water-soluble)-loaded PLGA MSs by means of conventional O/W solvent evaporation method. The size of MSs was in the range of 10~150 ${\mu}{\textrm}{m}$. The morphology of MSs was characterized by SEM, and the in vitro release amounts of FB were analyzed by HPLC. The lowest porous cross-sectional morphology and the highest encapsulation efficiency were obtained by using gelatin as an emulsifier. The influences of several preparation parameters, such as emulsifier types, molecular weights and concentrations of PLGA, and initial drug loading amount, etc., have been observed in the release patterns of FB. The release of FB in vitro was more prolonged over 25 days, with close to zero-order pattern by controlling the preparation parameters. We also investigated the physicochemical properties of FB-loaded PLGA MSs by X-ray diffraction and differential scanning calorimeter.

  • PDF

Controlled Release of Nerve Growth Factor from Sandwiched Poly(L-lactide-co-glycolide) Films for the Application in Neural Tissue Engineering

  • Gilson Khang;Jeon, Eun-Kyung;John M. Rhee;Lee, Ilwoo;Lee, Sang-Jin;Lee, Hai-Bang
    • Macromolecular Research
    • /
    • v.11 no.5
    • /
    • pp.334-340
    • /
    • 2003
  • In order to fabricate new sustained delivery device of nerve growth factor (NGF), we developed NGF-loaded biodegradable poly(L-lactide-co-glycolide) (PLGA, the mole ratio of lactide to glycolide 75:25, molecular weight: 83,000 and 43,000 g/mole, respectively) film by novel and simple sandwich solvent casting method for the possibility of the application of neural tissue engineering. PLGA was copolymerized by direct condensation reaction and the molecular weight was controlled by reaction time. Released behavior of NGF from NGF-loaded films was characterized by enzyme linked immunosorbent assay (ELISA) and degradation characteristics were observed by scanning electron microscopy (SEM) and gel permeation chromatography (GPC). The bioactivity of released NGF was identified using a rat pheochromocytoma (PC-12) cell based bioassay. The release of NGF from the NGF-loaded PLGA films was prolonged over 35 days with zero-order rate of 0.5-0.8 ng NGF/day without initial burst and could be controlled by the variations of molecular weight and NGF loading amount. After 7 days NGF released in phosphate buffered saline and PC-12 cell cultured on the NGF-loaded PLGA film for 3 days. The released NGF stimulated neurite sprouting in cultured PC-12 cells, that is to say, the remained NGF in the NGF/PLGA film at 37 $^{\circ}C$ for 7 days was still bioactive. This study suggested that NGF-loaded PLGA sandwich film is released the desired period in delivery system and useful neuronal growth culture as nerve contact guidance tube for the application of neural tissue engineering.

Controlled Release of Paclitaxel from Biodegradable Polymer Films for Drug-Eluting Stents (약물방출 스텐트용 생분해성 고분자 필름으로부터 파크리탁셀의 조절 방출)

  • Kim, Si-Eun;Lee, Bong-Soo;Kim, Jin-Hyang;Park, Kwi-Deok;Han, Dong-Keun
    • Polymer(Korea)
    • /
    • v.34 no.2
    • /
    • pp.172-177
    • /
    • 2010
  • Although many researchers have studied the efficacy of paclitaxel (PTX) on many cells during the last two decades, little work has been reported on the importance of release kinetics inhibiting cell proliferation. The aim of this study is to examine the release behavior of the PTX on various biodegradable polymers such as poly(lactic-co-glycolic acid)(PLGA), poly-L-lactide (PLLA), and polycaprolactone (PCL) for drug-eluting stents (DES). The PTX from the fabricated films was released for 8 weeks and the degree of degradation of the films was observed by FE-SEM. Although the degradation time of PCL was the slowest, the PTX release rate was the fastest among them and followed by PLGA and PLLA with the equivalent PTX concentration. It suggests that hydrophobic drug such as PTX from polymer with low $T_g$ like PCL could be moved easily and released rapidly in body temperature.

Preparation and Evaluation of Bupivacaine Microspheres by a Solvent Evaporation Method (용매증발법에 의한 부피바카인 microsphere의 제조 및 평가)

  • Kwak, Son-Hyok;Hwang, Sung-Joo;Lee, Byung-Chul
    • YAKHAK HOEJI
    • /
    • v.44 no.6
    • /
    • pp.511-520
    • /
    • 2000
  • Various bupivacaine-loaded microspheres were prepared from poly (d,l-lactide) (PLA) or poly (d,l-lactic-co-glycolide) (PLGA) by a solvent evaporation method for the sustained release of drug. PLA and PLGA microspheres were prepared by w/o/w and w/o/o multiple emulsion solvent evaporation, respectively. The effects of process conditions such as emulsification speed, emulsifier type, emulsifier concentration and internal/external phase ratio on the characteristics of microspheres were investigated. The prepared microspheres were characterized for their drug loading, size distribution, surface morphology and release kinetics. Drug loading efficiency was higher in the microspheres prepared by w/o/o multiple emulsion than that by w/o/w multiple emulsion method, because the solubility of bupivacaine HCI was decreased in oil phase compared with water phase. The prepared microspheres had an average diameter between 1 and $2\;{\mu}M$ in all conditions of two methods. In morphology studies the PLA microspheres showed an irregular shape and smooth surface, but PLGA microspheres had a spherical shape and smooth surface. The release pattern of the drug from microspheres was evaluated on the basis of the burst effect and the extent of the release after 24h. The in vitro release of bupivacaine HCl from microspheres showed a large initial burst release and $60{\sim}80%$ release within one day in all conditions of two methods. The extents of the burst release against PLA and PLGA microspheres were $30{\sim}50%$ and $50{\sim}80%$ within 20min, respectively. This burst release seems to be due to the smaller size of microspheres and the solubility of drug in water.

  • PDF

Synthesis and Properties of Multiblock Copolymers Consisting of Oligo(L-lactic acid) and Poly(oxyethylene-co-oxypropylene) with Different Composition

  • Lee, Chan-Woo
    • Macromolecular Research
    • /
    • v.9 no.5
    • /
    • pp.259-266
    • /
    • 2001
  • Multiblock copolymer was synthesized by the copolycondensation of oligo(L-lactic acid) prepared by thermal dehydration of L-lactic acid, Pluronic$\^$TM/(PN) and dodecanedioic acid as carboxyl/hydroxyl adjusting agent. This polycondensation proceeded by catalysis of stannous oxide to give the multiblock copolymers with high molecular weight and wide range of compositions. Polymer film was prepared by casting the chloroform solution of the multiblock copolymers having different composition. The multiblock copolymers having relatively high contents of poly(L-lactide) were melt spun into filaments which were subsequently drawn at 60$^{\circ}C$. The copolymer films and the filaments showed an improved flexibility due to the incorporation of the soft segments.

  • PDF